Filing Details
- Accession Number:
- 0001127602-20-004703
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-10 18:25:46
- Reporting Period:
- 2020-02-06
- Accepted Time:
- 2020-02-10 18:25:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1181185 | Per Olsen Wold | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94044 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-02-06 | 21,720 | $19.63 | 119,574 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-02-06 | 21,720 | $68.12 | 97,854 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-02-07 | 20,282 | $20.65 | 118,136 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-02-07 | 20,282 | $69.00 | 97,854 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2020-02-06 | 21,720 | $0.00 | 21,720 | $19.63 |
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2020-02-07 | 20,282 | $0.00 | 20,282 | $20.65 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2020-05-11 | No | 4 | M | Direct | |
0 | 2021-05-12 | No | 4 | M | Direct |
Footnotes
- Sale prices reported for the transactions reported here range from $68.1000 to $68.1750. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- The options vested quarterly over the first year of service and were fully vested on May 11, 2011.
- The options vested quarterly over the first year of service and were fully vested on May 12, 2012.